- Home
- INMB vs NMTC Comparison
INMB vs NMTC Comparison
Compare INMB & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INMB
- NMTC
- Stock Information
- Founded
- INMB 2015
- NMTC 2009
- Country
- INMB United States
- NMTC United States
- Employees
- INMB N/A
- NMTC N/A
- Industry
- INMB Biotechnology: Pharmaceutical Preparations
- NMTC Medical/Dental Instruments
- Sector
- INMB Health Care
- NMTC Health Care
- Exchange
- INMB Nasdaq
- NMTC Nasdaq
- Market Cap
- INMB 49.2M
- NMTC 45.0M
- IPO Year
- INMB 2019
- NMTC N/A
- Fundamental
- Price
- INMB $1.83
- NMTC $0.79
- Analyst Decision
- INMB Hold
- NMTC Strong Buy
- Analyst Count
- INMB 3
- NMTC 2
- Target Price
- INMB $4.30
- NMTC $2.23
- AVG Volume (30 Days)
- INMB 361.9K
- NMTC 476.2K
- Earning Date
- INMB 10-30-2025
- NMTC 12-16-2025
- Dividend Yield
- INMB N/A
- NMTC N/A
- EPS Growth
- INMB N/A
- NMTC N/A
- EPS
- INMB N/A
- NMTC N/A
- Revenue
- INMB $50,000.00
- NMTC $6,629,051.00
- Revenue This Year
- INMB $264.29
- NMTC $162.84
- Revenue Next Year
- INMB $9,819.61
- NMTC $26.51
- P/E Ratio
- INMB N/A
- NMTC N/A
- Revenue Growth
- INMB 19.05
- NMTC 69.00
- 52 Week Low
- INMB $1.71
- NMTC $0.40
- 52 Week High
- INMB $11.64
- NMTC $1.39
- Technical
- Relative Strength Index (RSI)
- INMB 44.66
- NMTC 40.55
- Support Level
- INMB $1.73
- NMTC $0.77
- Resistance Level
- INMB $1.89
- NMTC $0.89
- Average True Range (ATR)
- INMB 0.10
- NMTC 0.05
- MACD
- INMB 0.00
- NMTC -0.01
- Stochastic Oscillator
- INMB 37.04
- NMTC 16.43
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.
About NMTC NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.